drugset / Trial / NCT01734486

Growth Response in Girls With Turner Syndrome

NCT01734486

Phase 4 Completed 31 enrolled Novo Nordisk A/S
RandomizedParallel-groupOpen-labelTreatment

Summary

This trial is conducted in Europe. The aim of the trial is to evaluate growth response of two somatropin dose regimens in girls with Turner Syndrome.

Timeline

Start
1996-09-23
Primary completion
2003-05-21
Completion
2003-05-21

Drugs

EvaluationDrugModalityDoseRoute
Subject Somatropin Protein / enzyme biologic 0.9 iu/kg Subcutaneous
Subject Somatropin Protein / enzyme biologic 1.8 iu/kg Subcutaneous

Indications